ATE440960T1 - T-helferzellen-epitope - Google Patents

T-helferzellen-epitope

Info

Publication number
ATE440960T1
ATE440960T1 AT00906047T AT00906047T ATE440960T1 AT E440960 T1 ATE440960 T1 AT E440960T1 AT 00906047 T AT00906047 T AT 00906047T AT 00906047 T AT00906047 T AT 00906047T AT E440960 T1 ATE440960 T1 AT E440960T1
Authority
AT
Austria
Prior art keywords
epitopes
helper cell
cell epitopes
sgrrqrrfagvvlagva
fagvvlagvalgvataa
Prior art date
Application number
AT00906047T
Other languages
English (en)
Inventor
David Jackson
Souravi Ghosh
John Walker
Original Assignee
Univ Melbourne
Csl Ltd
Commw Scient Ind Res Org
Queensland Inst Med Res
Inst Medical W & E Hall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP8533A external-priority patent/AUPP853399A0/en
Priority claimed from AUPQ2013A external-priority patent/AUPQ201399A0/en
Application filed by Univ Melbourne, Csl Ltd, Commw Scient Ind Res Org, Queensland Inst Med Res, Inst Medical W & E Hall filed Critical Univ Melbourne
Application granted granted Critical
Publication of ATE440960T1 publication Critical patent/ATE440960T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Detergent Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00906047T 1999-02-05 2000-02-07 T-helferzellen-epitope ATE440960T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP8533A AUPP853399A0 (en) 1999-02-05 1999-02-05 T helper cell epitopes
AUPQ2013A AUPQ201399A0 (en) 1999-08-04 1999-08-04 T-helper cell epitopes
PCT/AU2000/000070 WO2000046390A1 (en) 1999-02-05 2000-02-07 T helper cell epitopes

Publications (1)

Publication Number Publication Date
ATE440960T1 true ATE440960T1 (de) 2009-09-15

Family

ID=25645983

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00906047T ATE440960T1 (de) 1999-02-05 2000-02-07 T-helferzellen-epitope

Country Status (15)

Country Link
US (5) US6685947B1 (de)
EP (2) EP2103691A1 (de)
JP (2) JP4699612B2 (de)
KR (2) KR100905264B1 (de)
AT (1) ATE440960T1 (de)
AU (1) AU765164B2 (de)
CA (1) CA2361658C (de)
CY (1) CY1109710T1 (de)
DE (1) DE60042816D1 (de)
DK (1) DK1147212T3 (de)
ES (1) ES2332701T3 (de)
NZ (1) NZ513482A (de)
PT (1) PT1147212E (de)
WO (1) WO2000046390A1 (de)
ZA (1) ZA200106413B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100905264B1 (ko) * 1999-02-05 2009-06-29 더 유니버시티 오브 멜버른 Ｔ 헬퍼 세포 에피토프
US20050106137A1 (en) * 2000-05-05 2005-05-19 Stephen Grimes Chimeric peptide immunogens
WO2002053106A2 (en) * 2001-01-05 2002-07-11 Joslin Diabetes Center, Inc. Autoantigen composition
CN101113178A (zh) 2002-08-12 2008-01-30 昆士兰医学研究所理事会 包含辅助t细胞和细胞毒性t淋巴细胞(ctl)表位的新免疫原性脂肽
BR0313154A (pt) 2002-08-12 2005-08-02 Council The Queensland Inst Of Novos lipopeptìdeos imunogênicos que compreendem epitopos de célula t-helper e de célula b
US7178491B2 (en) * 2003-06-05 2007-02-20 Caterpillar Inc Control system and method for engine valve actuator
KR20070056042A (ko) * 2004-06-17 2007-05-31 맨카인드 코포레이션 에피토프 유사체
AU2005282231B2 (en) * 2004-09-10 2011-03-10 The Council Of The Queensland Institute Of Medical Research (Qimr) Truncated LHRH formulations
NZ554332A (en) * 2004-09-10 2010-01-29 Queensland Inst Med Res Truncated LHRH formulations with T helper cell epitopes
JP2008539169A (ja) 2005-04-19 2008-11-13 イーライ リリー アンド カンパニー 疾患における免疫学的介入のための一価および多価合成多糖類抗原
BRPI0611390A2 (pt) * 2005-06-01 2010-09-08 Pfizer Prod Inc composições de vacina e uso de composições compreendendo vacina anti-lhrh na preparação de um medicamento para tratar incontinência urinária
AU2006259307B2 (en) * 2005-06-17 2012-12-20 Mannkind Corporation Epitope analogues
ES2413079T3 (es) 2005-06-17 2013-07-15 Mannkind Corporation Métodos y composiciones para desencadenar respuestas inmunitarias multivalentes contra epítopos dominantes y subdominantes expresados en células cancerosas y estroma tumoral
WO2007127787A2 (en) * 2006-04-25 2007-11-08 Joslin Diabetes Center, Inc. Insulin autoantigen-specific regulatory cd4+ t cells
CO2021017322A1 (es) * 2021-12-16 2023-06-20 Univ Cooperativa De Colombia Péptidos inmunogénicos contra el virus distemper canino (cdv)
CN115960262A (zh) * 2022-10-19 2023-04-14 四川农业大学 展示cdv抗原表位的犬细小病毒样颗粒及构建方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047238A (en) 1983-06-15 1991-09-10 American Home Products Corporation Adjuvants for vaccines
US6309647B1 (en) * 1999-07-15 2001-10-30 Aventis Pasteur Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
WO1998034968A1 (en) 1997-02-11 1998-08-13 The Council Of The Queensland Institute Of Medical Research Polymers incorporating peptides
KR100905264B1 (ko) * 1999-02-05 2009-06-29 더 유니버시티 오브 멜버른 Ｔ 헬퍼 세포 에피토프

Also Published As

Publication number Publication date
US20060199177A1 (en) 2006-09-07
KR100905264B1 (ko) 2009-06-29
US20070248615A1 (en) 2007-10-25
KR20010101796A (ko) 2001-11-14
JP2002536384A (ja) 2002-10-29
EP1147212A4 (de) 2004-03-31
JP4699612B2 (ja) 2011-06-15
EP2103691A1 (de) 2009-09-23
WO2000046390A1 (en) 2000-08-10
US7241448B2 (en) 2007-07-10
US20050037014A1 (en) 2005-02-17
KR20090015892A (ko) 2009-02-12
CA2361658A1 (en) 2000-08-10
KR100955668B1 (ko) 2010-05-06
EP1147212B1 (de) 2009-08-26
AU2783600A (en) 2000-08-25
AU765164B2 (en) 2003-09-11
DE60042816D1 (de) 2009-10-08
CY1109710T1 (el) 2014-08-13
ES2332701T3 (es) 2010-02-11
EP1147212A1 (de) 2001-10-24
ZA200106413B (en) 2002-08-05
DK1147212T3 (da) 2010-01-04
PT1147212E (pt) 2009-12-03
US7572454B2 (en) 2009-08-11
CA2361658C (en) 2013-04-09
NZ513482A (en) 2003-08-29
US7097844B2 (en) 2006-08-29
US20050186220A1 (en) 2005-08-25
US7037507B2 (en) 2006-05-02
US6685947B1 (en) 2004-02-03
JP2011121965A (ja) 2011-06-23

Similar Documents

Publication Publication Date Title
CY1109710T1 (el) Επιτοπα βοηθητικων τ λεμφοκυτταρων
TR199900267T2 (xx) GnRH-L�kotoksin kimeralar�.
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
NO20002800D0 (no) Cyklosporinholdig mikroemulsjon, forkonsentratsammensetning
CY1106366T1 (el) Ενωση λακταμης για την αναστολη της απελευθερωσης ή της συνθεσης βητα-αμυλοειδους πεπτιδιου
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
DE50202328D1 (de) Amidofunktionelle aminopolydiorganosiloxane
DK1200418T3 (da) Nematodicide trifluorbutener
ATE376591T1 (de) Neisseria meningitidis antigene und zusammenstellungen
DK1353689T3 (da) Immuniseringspræparater og anvendelse deraf
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
DE60230456D1 (de) Faktor-viii-polypeptide auf hohem expressionsnivea und verwendungsverfahren
GB2301591A (en) Cytotoxic T-cell epitopes
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
NO20073914L (no) Biologisk aktive peptider
SE9802937D0 (sv) Novel compounds
ZA200202802B (en) Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same.
ATE473283T1 (de) Dna-expressionsvektoren
DE69426121D1 (de) Gen grb3-3, variante und ihre verwendungen
DE69738512D1 (de) Epstein-barr virus type b ctl epitopen
IL139604A0 (en) Novel peptides
DE69637243D1 (de) Atelocollagen enthaltende gen-zusammensetzungen
FI943069A7 (fi) Kloorittomia, mahdollisesti vetypitoisia fluorihiilivetyjä sisältävät koostumukset
ES2218796T3 (es) Uso de un compuesto peptidico para el tratamiento del lupus erimatoso sistemico.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1147212

Country of ref document: EP